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Abstract
Congenital Diaphragmatic Hernia (CDH) is defined by the presence of an orifice in the diaphragm, more often left
and posterolateral that permits the herniation of abdominal contents into the thorax. The lungs are hypoplastic
and have abnormal vessels that cause respiratory insufficiency and persistent pulmonary hypertension with high
mortality. About one third of cases have cardiovascular malformations and lesser proportions have skeletal, neural,
genitourinary, gastrointestinal or other defects. CDH can be a component of Pallister-Killian, Fryns, Ghersoni-Baruch,
WAGR, Denys-Drash, Brachman-De Lange, Donnai-Barrow or Wolf-Hirschhorn syndromes. Some chromosomal
anomalies involve CDH as well. The incidence is < 5 in 10,000 live-births. The etiology is unknown although clinical,
genetic and experimental evidence points to disturbances in the retinoid-signaling pathway during organogenesis.
Antenatal diagnosis is often made and this allows prenatal management (open correction of the hernia in the past
and reversible fetoscopic tracheal obstruction nowadays) that may be indicated in cases with severe lung
hypoplasia and grim prognosis. Treatment after birth requires all the refinements of critical care including
extracorporeal membrane oxygenation prior to surgical correction. The best hospital series report 80% survival but
it remains around 50% in population-based studies. Chronic respiratory tract disease, neurodevelopmental
problems, neurosensorial hearing loss and gastroesophageal reflux are common problems in survivors. Much more
research on several aspects of this severe condition is warranted.
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Disease name/synonyms
Congenital Diaphragmatic Hernia (CDH), ORPHA2140,
OMIM 142340, 610187, 306950 and 222400
Definition
CDH consists of a posterolateral defect of the dia-
phragm, generally located on the left side, that allows
passage of the abdominal viscera into the thorax. The
mediastinum is displaced to the contralateral side, the
lungs are hypoplastic (Figure 1) and their arterioles are
abnormal causing pulmonary hypertension. Respiratory
and cardiovascular functions are severely compromised
at birth and this, together with the frequently associated
malformations, cause considerable mortality and mor-
bidity. CDH was described many years ago [1,2] but sur-
vival after repair was not achieved until the 20
th century.
Pioneers of pediatric surgery [3] reported amazingly low
mortalities until the actual severity of the condition
surfaced when abortions, stillbirths and pre-hospital
deaths were considered, adding a “hidden mortality” to
operative and postoperative demises [4]. The pathophy-
siology of lung insufficiency and persistent pulmonary
hypertension that threaten survival are currently better
understood, but the results remain disappointing since
mortalities near 50% are still reported when all deaths
are taken into account in population-based series [5].
CDH management indeed remains one of the major
challenges of perinatal medicine and surgery and active
research on its mechanisms is warranted.
Epidemiology
CDH is a rare condition that occurs in < 1-5:10000
births [6]. It seems to be slightly more frequent in males
and less frequent in blacks [7,8].
Clinical features
CDH can be detected during fetal life when screening
ultrasonography demonstrates herniation of the intestine
and/or the liver into the thorax. Polyhydramnios may
lead to antenatal diagnosis in some severe cases [9].
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tory distress with insufficient oxygenation, excavated
abdomen with sternal protrusion and displacement of
the heart sounds to the contralateral side. In severe
cases, APGAR scores at 1 and 5 minutes are low
[10,11]. Respiratory bruits are absent or decreased on
the affected side. Unless energetic treatment is under-
taken, respiratory condition deteriorates rapidly until
the patient dies. The symptoms of insufficient gas
exchange are associated with those of persistent pul-
monary hypertension [12,13] caused by arteriolar con-
striction and closure of the pulmonary arterial bed
that forces maintenance of a pattern of persistent fetal
circulation in which the blood from the right ventricle
is shunted to the left heart preventing effective gas
exchange. In some cases, this pulmonary hypertension
intervenes after some hours during which adaptation
to a post-natal circulatory pattern with patent pul-
monary circulation had taken place. Hypoxia, acidosis,
stress or other causes may bring this “honeymoon”
period to an end and re-establish the fetal pattern
[14].
In some cases without neonatal symptoms, CDH may
manifest itself at any age by mild respiratory distress or
it can even be an unexpected finding during a medical
check-up for other reasons [15]. In these cases, a hernial
sac is more often present [16].
Other organs may be involved in CDH [17] because
associated malformations are frequent [18]. The heart
and great vessels are often abnormal in CDH patients.
Cardiovascular defects like peri-membranous ventricular
septal defect, cardiac outflow anomalies (tetralogy of
Fallot, double outlet right ventricle, transposition of the
great vessels and others) and abnormal great vessels
(right aortic arch, double aortic arch, truncus arteriosus,
abnormal subclavian arteries and others) are found in
about one third of CDH patients [19,20]. Heart hypopla-
sia, particularly of the left side [21], has also been
described [22] but its participation in the clinical picture
is still unclear.
Musculoskeletal defects like anomalies of the limbs or
of the number and shape of the vertebral bodies and/or
ribs [18,23-25], neural tube defects [18,26], abdominal
wall defects [27], craniofacial defects [28] or urinary
tract anomalies [29] are also found. The parafollicular
C-cells [30] and enteric innervation are deficient and
might account for some dysfunctions [31]. Finally, the
presence of the intestine in the thorax during late fetal
development causes malrotation and/or malfixation [32]
that can further complicate the disease [33].
Etiology
The causes of CDH are largely unknown. Most cases are
isolated, but associated malformations are often
Figure 1 A: Plain X-ray of the thorax of a newborn with CDH. There are bowel loops into the left hemi-thorax, the mediastinum is displaced
to the contralateral side and the space occupied by the lung is reduced. B and C: At laparotomy, a left, posterolateral diaphragmatic hernia was
discovered. In B, small bowel loops can be seen entering the thorax through the orifice. In C, this is seen after reducing the contents of the
hernia. D: The patient died of severe persistent pulmonary hypertension days later. At autopsy, extreme left lung hypoplasia and less severe right
lung hypoplasia were discovered.
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Killian and Fryns [35], Ghersoni-Baruch [36], WAGR
and Denys-Drash [29,37], Brachman-De Lange [38],
Donnai-Barrow [39] or Wolf-Hirschhorn [40] syn-
dromes. CDH is also observed in some chromosomal
anomalies whether related or not to these syndromes
like 9p tetrasomy [41], 11q23-qter duplication [42],
15q24-26 [43], 15q26 [44], 1q41-q42.12 [39,45] and
8p23.1 [46] deletions. Null-mice for several genes, like
shh transcription factors Gli 2 and Gli3 [47], Slit3
[48,49], COUP-TFII [50], Fog2 [51], Wt1 [52] and
FGFLR-1 [53] have CDH.
The orifice in the diaphragm is caused by delayed or
disturbed separation of the thoracic and abdominal
compartments of the body by closure of embryonic
pleuroperitoneal canals effected by growth of the post-
hepatic mesenchymal plate and of the pleuroperitoneal
folds [54-57].
CDH occurs more often on the left side (4:1) [58]. In
some rare instances [59], the defect is a true agenesis of
the hemidiaphragm [60], but in most cases it is limited
to the posterolateral area. Less often, there is a hernial
sac devoid of muscular fibers [16]. When the defect is
located on the left side, the thorax may contain small
and large bowel, the spleen, the stomach, the left lobe of
the liver and, occasionally, the kidney. Right-sided CDHs
usually contain part of the right lobe of the liver and
sometimes the bowel and/or the kidney.
The lung is obviously hypoplastic on the side of the
hernia, but the contralateral one is also affected to a
variable extent. Lung weight is decreased and the num-
ber of alveoli is reduced due to insufficient branching
[61]. Respiratory epithelial maturity is delayed with hya-
line membrane disease patterns similar to those found
in prematures [62]. Surfactant deficiency has been
shown [63-65] although this issue is controversial [66].
The distal bronchiolar arteries have muscularized walls
and the wall thickness is increased particularly at the
expense of the media and adventitial layers [67,68].
The lung hypoplasia, immaturity and arteriolar thick-
ening that accompany human CDH can be due to pre-
natal compression of the lung by the herniated viscera.
All these lesions can be reproduced by surgically creat-
ing a CDH in rabbits [69-71] lambs [72-74] and pri-
mates [75]. These models were used for investigating
various aspects of CDH and also for developing fetal
surgery [76-81]. However, the associated malformations
are absent in these mechanical or surgical models and
this limits to some extent their validity as research tools.
In fact, the assumption that lung hypoplasia is purely
mechanical is probably incorrect because it is already
present in teratogenic models of CDH before any her-
niation has taken place. A “dual hit” pathogenesis [82],
in which abnormal development followed by
compression cause lung hypoplasia is widely accepted.
Regardless of the origin of the lung lesions, these consist
of insufficient airway branching [61,63,83], reduced gas
exchange surface, abnormal sacculo-alveolar maturation
[64,84] and abnormal, muscularized distal arterioles
[68,85].
Pharmacologic or teratogenic models of CDH have
been crucial for unveiling some pathogenic mechanisms.
Prenatal administration of oxidant chemicals like the
herbicide nitrofen (2,4-dichloro-phenyl-p-nitrophenyl
ether), 4-biphenyl carboxylic acid, bisdiamine, and SB-
210661, induce CDH in rodent fetuses. These chemicals
inhibit in vitro retinol-dehydrogenase-2 (RALDH-2) a
key enzyme for the production of retinoic acid (RA)
[86]. Among these agents, nitrofen has been the more
extensively used [54-56,87-97] because of the striking
resemblance of the diaphragmatic, pulmonary and other
associated defects to those of the human condition (Fig-
ure 2). Proliferation of the pleuroperitoneal folds is
arrested in rats with CDH [98] and the timing of this
arrest probably conditions the laterality of the defect.
Fibroblast growth factor (FGF) receptor-like 1 (FGFRL1)
[99] and WT1 [97] are downregulated in these
diaphragms.
Figure 2 Experimental CDH in rats. Administration of 100 mg of
the herbicide nitrofen on gestational day 9.5 to pregnant rats
induced the malformation in 40 to 80% of the offspring. On the left,
neonatal autopsy of an untreated, wild-type rat shows an intact
diaphragm (above) that can also be seen in the frontal section of
the trunk (below). On the right, similar preparations of a rat with
nitrofen-induced CDH show a large postero-lateral diaphragmatic
orifice, herniation of the liver into the thorax, displacement of the
mediastinum to the contralateral side and lung hypoplasia.
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these models is not well known, disturbances of the reti-
noid signalling pathway, a key regulator of embryonic
morphogenesis, are likely [90]. Vitamin A deficient-rats
give birth to pups with CDH [100]. RA metabolism per-
turbations caused by nitrofen can be alleviated by addi-
tion of either vitamin A or RA [95,101-103].
Hypoplastic lungs from rats with nitrofen-induced CDH
show decreased RA synthesis [104] and deficient retinol
transportation [105], whereas RA rescues lung hypopla-
s i a[ 9 3 ]p r o b a b l yb yu p r e g u l a t i n gC O U P - T F I I ,F O G 2 ,
and GATA4 [106] that are known to be necessary for
both pulmonary and diaphragmatic development
[39,50]. On the other hand, compound knock-out mice
for retinoic acid receptors (RAR) have phenotypes invol-
ving CDH and several of the associated malformations
seen in this condition [107] whereas blockade of RAR
with BMS493 induces CDH [108] and administration of
BMS-189453, a RA antagonist, to pregnant mice repro-
duces the phenotype of CDH [109].
A similar involvement of the retinoid signaling path-
way is likely in human CDH because retinol and retinol-
binding protein were decreased in the blood of a group
of newborns with this malformation [110]. This has
recently been confirmed in a larger case-control study
[111]. Moreover, some of the genes involved in the
pathogenesis of human CDH are tightly related to reti-
noid signaling [112-115].
Another factor that might contribute to lung hypopla-
sia in CDH is decreased airway pressure during fetal life.
Fetuses with tracheal atresia have large lungs [116,117]
whereas fetal tracheostomy induces lung hypoplasia
[118]. It has been shown that airway peristalsis is abnor-
mal in lung explants from rat embryos treated with
nitrofen and it is likely that decreased airway pressure
could contribute to hypoplasia [92,119].
Diagnosis
As mentioned before, CDH is often ultrasonographically
diagnosed before birth [120,121]. The intestine and/or
the liver may be in the thorax and the lungs are small.
US scan allows detailed assessment of the heart. Lung
growth is measured as a proportion of head growth.
This lung-to-head ratio (LHR) has some prognostic
value [122-127] because when it is below 1, survival is
compromised [125,128,129]. However, the accuracy of
these measurements is questionable [130] and other
alternatives like lung/thorax (L/T) transverse area ratio
[126,131] or volumetry by MRI have been developed
[132-136]. The observed-to-expected LHR (o/e LHR)
seems to be a reliable predictor of severity (patch
requirement, ECMO) and survival [127,137]. The posi-
tion of the liver is also of unquestionable value, since
liver-up cases more often require ECMO support and
have worse survival [138-140]. The intra-thoracic posi-
tion of the stomach has less value for this purpose
[141,142]. When diagnosis is made in utero, amniocent-
esis is often performed for detecting chromosomal aber-
rations [143] and may help to estimate lung maturity
[64].
After birth, the diagnosis is readily made on the basis
of symptoms and physical signs. A plain X-ray of the
thorax and abdomen informs of the position of the her-
niated viscera. Blood gases and pH status reflect the effi-
ciency of gas exchange and other derived indexes refine
this assessment [144,145]. Ultrasonography of the heart
is necessary for ruling-out associated malformations, for
measuring the right-to-left shunt and for estimating the
severity of pulmonary hypertension [146-148]. Measure-
ments of the pulmonary artery diameters and the use of
some indexes derived from them may facilitate this task
[149-151]. Cardiac U.S. is one of the more reliable
methods for determining when the patient is
“stabilized”.
Differential diagnosis
It is rarely necessary to rule out other conditions
because CDH is often detected before birth and because
diagnosis is easy. Physical exam may suffice but passing
a naso-gastric catheter into the stomach before a plain
X-ray of the thorax and abdomen may help to locate it
or to detect esophageal displacement. In some rare
instances, X-rays may suggest a cystic malformation of
the lung but again the position of the stomach and the
contour of the intra-abdominal gas bubbles facilitate dis-
tinction of both conditions.
Treatment before birth
Since the introduction of routine prenatal U.S. screen-
ing, a large proportion of fetuses with CDH are diag-
nosed in utero. Termination of gestation is sometimes
preferred, particularly when chromosomal aberrations
and syndromes are present [5,152-154]. The possibility
of fetal instrumentation directed to alleviate the conse-
quences of the herniation is becoming a progressively
more acceptable alternative. Thirty years ago Harrison
and coll. started pioneer work in San Francisco aimed at
developing animal models of CDH on which to test the
effects of prenatal manipulation. After demonstrating in
fetal lambs that lung compression led to lung hypoplasia
[73] and that prenatal decompression reversed this con-
dition [72], this group undertook the surgical creation of
CDH [74] and later on, the demonstration of reversal of
lung hypoplasia and arteriolar thickening when the dia-
phragmatic defect was repaired before birth [155]. Clini-
cal application of this rationale led, with close
consideration of all the ethical and technical issues
involved, to the first attempts at prenatal repair of CDH
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liver [138] and the demonstration of the lethal effect of
umbilical vein compression during fetal reduction of the
left lobe of the liver into the abdomen during surgery
[74], limited considerably the number of cases suitable
for this approach. Furthermore, a randomized study
demonstrated that fetal repair did not produce better
outcomes than optimal postnatal treatment [158]. The
trial was discontinued andan e wa p p r o a c h ,b a s e do n
the observation of lung hyperplasia in congenital tra-
cheal obstruction, was developed. The evidence that air-
way pressure had something to do with lung
development led to assume that tracheal occlusion dur-
ing fetal life could counteract the effects of lung com-
pression in fetuses with CDH. This was tested in the
fetal lamb [77,78,159-161] and then in the human fetus
[162,163]. Another randomized trial was discontinued
when a significant shortening of gestation was observed
in fetuses treated in this manner [164]. However, the
effects of tracheal occlusion were indeed very positive in
terms of alveolar size and histology [159]. Maturation
and surfactant function were apparently not so much
improved, unless the plug was reversed before delivery
[165].
The concurrent development of minimally invasive
surgery had the immediate effect of making fetendo-
scopic balloon tracheal occlusion possible [75,163]. Con-
siderable experience rapidly accumulated and
randomized trials are currently underway concentrating
these efforts in fetuses with LHR below 1 considered
otherwise unviable [166]. Survivals approaching 50% in
this group are encouraging [139] and much information
has already accumulated on the structure, maturity and
tracheal pathology of survivors.
Experimental and clinical evidence suggest that bio-
chemical lung maturation is delayed in fetuses with
CDH [65,167-169] and this led to the proposal that this
process be accelerated by administration of maternal
corticosteroids as it is done for premature deliveries.
The evidence of the benefits of this medication is not
totally convincing [170,171] and therefore, a multicenter
trial could be necessary [172].
Treatment after birth
Whenever prenatal diagnosis is made, it is advisable to
direct the mother to a tertiary perinatal center in which
all the necessary obstetric, neonatal and surgical skills
are concentrated [173]. Gestation should be prolonged
until near term if possible [174] (this can be hard to
achieve in cases with polyhydramnios) and, although it
is often preferred [175], there is no evidence of the ben-
efits of delivery by Cesarean section [174,176,177].
When CDH becomes symptomatic after birth and in
all cases diagnosed prenatally, a careful protocol of
respiratory assistance should be implemented. Immedi-
ate postnatal intubation avoiding mask ventilation
should be carried out, and small-volume, high frequency
and reduced peak pressure mechanical ventilation
should be started. Oxygen delivery has to be tailored for
maintaining pre-established gasometric goals. Surfactant
has been used in an attempt to compensate for bio-
chemical immaturity in CDH babies [178,179], but this
has not been beneficial [180,181]. The stomach is emp-
tied through a nasogastric tube and vascular accesses
(peripheral and central veins, umbilical artery) are
secured for infusion of fluids, drug administration and
blood sampling. A bladder catheter is inserted and urine
output is monitored. Then, a period of assessment of
the chances of adequate gas exchange is started adapting
all actions to the clinical findings. If arterial oxygenation
is maintained above a preset minimum, the lung will
probably be capable of adequate gas exchange. Pre-duc-
tal and post-ductal percutaneous oxygen saturation mea-
surements help in the assessment of both the adequacy
o ft h el u n g st os u s t a i nl i f ea n do ft h em a g n i t u d eo f
right-to-left shunting. Inotropic drugs are used as neces-
sary and cardiac function and heart anomalies are care-
fully evaluated. Persistent pulmonary hypertension may
cause right ventricle dysfunction and in these cases,
maintenance of the patency of the ductus arteriosus is
indicated [182].
After years of frustrating results of application of
respiratory assistance goals usually applied to other con-
ditions, it was realized that the hypoplastic and probably
immature lung of CDH was severely damaged by exces-
sive oxygen delivery and, particularly by excessive airway
pressure that led to pneumothorax, barotrauma and
volutrauma [183,184]. Mortality decreased drastically
and all these untoward consequences of ventilator assis-
tance became milder when a policy of “gentle ventila-
tion” was implemented [185]. Spontaneous ventilation
when possible or high frequency, low pressure ventila-
tion (< 20-25 cm H2O), no relaxation, alkalinisation and
adoption of modest gasometric goals (pre-ductal satura-
tion of 80-95%, PaO2 around 60 mmHg and “permis-
sive” hypercapnia of up to 60 mmHg) drastically
changed the results [186]. This policy progressively
gained adepts and it is nowadays the standard in most
developed countries [187-189].
High-frequency, oscillatory ventilation is also widely
used in these patients [190-192] in whom it allows ade-
quate oxygenation and CO2 elimination with very low
airway pressures [193]. Lung damage is apparently mini-
mized while attaining the modest gasometric objectives
set. A multicenter European trial is currently underway
[194].
For how long time these treatments are necessary var-
ies widely from one patient to another depending on the
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and therefore on the duration of persistent pulmonary
hypertension and on the associated malformations, par-
ticularly the cardiovascular ones.
The treatment of pulmonary hypertension is of parti-
cular concern because it determines shunting of non-
oxygenated blood out of the lungs. Several medications
have been used: tolazoline [67,195,196] and prostacy-
clins [197,198] were tried first but they did not produce
good enough results. Prostaglandin 1E is occasionally
used [199]. Inhaled nitric oxide, a well known smooth
muscle relaxant is, in turn, widely used [200-203] with
variable results although there is no strong evidence of
its benefits [204]. Inhibitors of phospho-diesterase like
sildenafil, known for their vasodilator action, are cur-
rently used in some cases [205] but, again, there is only
anecdotal evidence of their benefits. These medications
are coupled with inotropic agents, like dobutamine (up
to 20 mg/kg/min), dopamine (< 10 mg/kg/min) [206]
and also, sometimes with peripheral vasoconstrictors,
like adrenaline at low doses, aimed at reducing the
shunting by increasing pressure in the systemic
circulation.
ECMO
Extra-corporeal membrane oxygenation (ECMO) may be
a useful adjunct in the treatment of CDH. Cannulation
of both the right carotid artery and jugular vein and
connection to a circuit with a membrane gas exchange
chamber allows oxygenation and CO2 disposal without
participation of the lung which is preserved from any
pressure insult [207]. Alternatively, veno-venous ECMO
avoids cannulation of the carotid artery while permitting
adequate gas exchange [208-210].
ECMO can be seen as a safety net maintained until
proper gas exchange is demonstrated at weaning test
periods. The fact that institutions, particularly in the US,
which used ECMO liberally [10] had results comparable
to Canadian institutions [211] that rarely, if ever, used
it, casted some doubt on the actual need for this com-
plicated and risky procedure [12,212]. The criteria for
ECMO indication are variable, but they can be summar-
ized as follows: Inability to reach pre-ductal SatO2 >
85% or post-ductal SatO2 >7 0 % ,o x y g e n a t i o ni n d e x
(mean airway pressure × FiO2 × 100/PaO2) ≥ 40 or
need for high peak inspiratory pressures or a-AdO2
greater than 600 for 6 to 8 hours [213]. The main con-
traindication is, of course, the inability to obtain SatO2
> 80% at any moment of the initial treatment under
FiO2 of 1. In fact, ECMO registries showed that the
worst results were obtained precisely in the CDH group
of patients [214,215]. This, together with the limitations
of the technique (required weight above 2000 g, need
for heparinisation), somewhat tempered the initial
enthusiasm and the proportion of patients so treated
decreased everywhere to more reasonable figures. There
is only weak evidence of the benefits of ECMO in this
particular group of patients [216] because only non-ran-
domized trials have been carried out on them [171,212]
and the only RCT reported in the UK was not specifi-
cally directed to babies with CDH [217]. This technique
is probably a good adjunct in a limited number of
patients in which predicted severe lung hypoplasia
would make adequate gas exchange impossible or in
those in whom reversal to the fetal pattern of circulation
becomes unmanageable.
Surgical repair
Surgical repair of CDH used to be in the past a life-sav-
ing emergency. It is presently accepted that it should be
undertaken only after cardio-respiratory functions are
stable. A policy of “delayed” surgery coupled with gentle
ventilation and occasionally ECMO support yields the
best results recorded. For how long surgery has to be
delayed is unclear, but a few days and even weeks may
be beneficial. The goal of all preoperative treatments is
to obtain “stabilization” of the patient and this means
acceptable oxygenation (PaO2 >4 0m m H g )a n dC O 2
disposal (PaCO2 < 60 mmHg) with stable pulmonary
pressures (< 50% of systemic pressure), tolerable shunt-
ing, good myocardial function and adequate renal clear-
ance with reduced or withdrawn inotropic drugs.
Obviously, there are no magic indicators of stabilization
(this may also be impossible) and a decision to operate
is only made after a consensus among all the actors of
these treatments has been reached. Once again, when
critically reviewed, even the alleged benefits of delayed
repair are not consistently documented [218].
In many institutions, the operation is carried out in
the neonatal ICU in order to minimize changes that
might increase stress [219-221]. Under general anesthe-
sia, a subcostal or transverse abdominal incision is
made, the herniated viscera are carefully reduced into
the abdomen and the diaphragmatic orifice is closed
with interrupted sutures without leaving an intercostal
tube. A tube was routinely used in the past [58,222]
until it was realized that underwater seals cause
increased respiratory work and overdistension of the
hypoplastic lung that may further reduce ventilation. A
tubeless policy was then advised [185,223]. When the
defect is too large, a prosthetic patch is used to achieve
closure [224,225]. It is sutured to the rims of the orifice
with interrupted sutures and, to avoid excessive tension
and enlargement of the hemi-thorax, cone-shaping of
the patch can be beneficial [226]. The use of a patch
seems to increase the risk of re-herniation [227-230]
although it should be acknowledged that patients requir-
ing a patch have larger defects which entail higher
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cle flaps have also been used for CDH repair [231-234].
Malrotation or non-rotation is usually present but this
is rarely a problem in the newborn and the main con-
cern of the surgeon after repair of the hernia is abdom-
inal wall closure without excessive pressure [235,236]. In
some cases, another abdominal wall prosthetic patch is
necessary to avoid abdominal compartment syndrome
[237-239].
Since the advent of minimally invasive surgery (MIS),
thoracoscopic [240-246] or laparoscopic [247]
approaches have been proposed for CDH repair. Both
are indeed possible (with or without patch insertion),
although it should never be disregarded that this repair
comes only after stable conditions have been secured.
Probably, MIS is a good approach in cases diagnosed
during infancy or in outborns with less severe symp-
toms. Nevertheless, some concerns about this particular
approach in the newborn period have been expressed on
the basis of excessive perioperative hypercapnia and pro-
longed postoperative low brain oxygenation [248]. The
risk of recurrence after a minimally invasive approach
has been found to be similar to that of open surgery by
some reports [246] but it was indeed increased in other
series [248,249].
Prognosis
The main outcome endpoint is, of course, survival and
the wide range of figures reported is puzzling. When only
hospital, postoperative results were reported, survival
approached 70% [250] or more [189,251,252]. However,
those institutions with attached maternity facilities that
treated mostly inborns, reported higher mortalities. The
introduction of ECMO, in parallel with advances in other
aspects of treatment, improved the results and the top
institutions reported survivals approaching 90% although,
sometimes, their statistics excluded chromosomal aberra-
tions, multiple malformations and even some patients
that did not reach surgery. The truth is that still nowa-
days, if terminations of pregnancy, spontaneous abor-
tions, stillborns, pre-hospital and/or preoperative deaths
and surgical mortality are taken into account, real mor-
tality is still between 50% and 60%. But if only hospital
statistics are considered, there has been indeed a clearcut
progress in the results. Many institutions and the multi-
institutional registries report 70% to 80% survival with
some institutions peaking at 90%. Right-sided hernias
seem to have a worse prognosis than left-sided ones and
may require more ECMO support [253-255].
Other in-hospital complications can occur after CDH
repair. Pleural effusions and chylothorax may require
nutritional treatment, medication and drainage
[256-260].
Chronic respiratory tract disease is frequent in these
patients. Lung hypoplasia can be caught up only in part
during the first months of life and oxygen toxicity, baro-
trauma and volutrauma may occur even after gentle
ventilation. True broncho-pulmonary dysplasia is rela-
tively frequent in survivors [250,261], and a number of
them require oxygen at home for long periods of time
[228,251]. Restrictive [262-264] and obstructive
[263-265] lung diseases have been reported in CDH sur-
vivors many years after operation and diaphragmatic
rigidity and thoracic deformities can also play a minor
role in chronic lung disease [266-268].
Gastroesophageal reflux is frequent in CDH survi-
vors. The diaphragmatic sling may be malformed or
absent and the repair changes the anatomy of the
region. In addition, mal-rotation may delay gastric
emptying, and the abnormal balance of pressures in
the thorax and abdomen in the course of the respira-
tory cycle facilitates retrograde passage of gastric con-
tents to the esophagus [269]. Finally, there is evidence
of abnormal enteric innervation in CDH and it is likely
for esophago-gastric peristalsis to be abnormal
[96,270]. Reflux can complicate the pre-existing
respiratory disease and, for all these reasons, a consid-
erable proportion of these patients [271,272] respond
poorly to medical treatment and ultimately require
anti-reflux surgery [227,273-276]. Prophylactic fun-
doplication during surgical repair has been proposed in
patients with CDH [277]
Neurodevelopmental deficits are always possible in
these patients in whom brain oxygenation was marginal
for long periods of time and particularly when ECMO
required major vascular occlusion [228,278-283]. Neuro-
sensorial deafness occurs in a small proportion of chil-
dren surviving CDH [283-290]. This is progressive
[287,291] and it is generally considered to be accounted
for by prolonged antibiotic treatments [288]. However,
other newborns with similar treatments suffer this deaf-
ness more rarely and it should be acknowledged that
perhaps CDH patients have a particular sensitivity or a
developmental defect of the inner ear.
Other sequelae are possible in this particular group of
patients. This, and the frequent associated malforma-
tions, require long-term follow-up and permanent
support.
Genetic counseling
Most cases are sporadic but there are some reports of
familial clusters that suggest multifactoral [292-296]
rather than autosomal recessive [297,298] patterns of
inheritance. Genetic aspects of CDH were recently
addressed [299-302]. Two thirds of these cases were
males and the risk of recurrence in sibs is 2% [294].
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CDH remains one of the most difficult problems of
perinatology and neonatal surgery. Its mechanisms are
beginning to be unveiled, but the severity of the lung
and other lesions require the use of the entire arma-
mentarium of sophisticated neonatal care. This, together
with the rarity of the condition, make the setting of
solid evidence-based protocols of management very dif-
ficult. The perspectives of fetal manipulation or even of
prophylactic drug treatment remain still at an embryo-
nal stage and, most probably, this condition will remain
a hot topic of research in the coming years.
Conclusions
CDH is a complex condition probably caused by dis-
turbed molecular signaling during organogenesis. The
diaphragmatic orifice is invariably accompanied by pul-
monary hypoplasia with vascular hyper-reactivity that
causes deficient gas exchange and persistent pulmonary
hypertension. In addition, other malformations that
further complicate the clinical course may be present.
All efforts are directed at enhancing antenatal lung
growth in prenatally diagnosed cases and at protecting
the lung during the intensive care pre and post-opera-
tive phases in all cases. Fetoscopic reversible tracheal
obstruction seems promising before birth and gentle
ventilation with occasional ECMO use yields the best
results post-natally. Nevertheless, many aspects of the
disease are still unknown and, given that the incidence
is relatively high, that the expenses involved in the cur-
rent treatments are overwhelming and that the sequelae
are frequent, more research efforts into causation, pre-
vention and treatment are warranted.
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